JF
SLDB icon

Jump Financial’s Solid Biosciences SLDB Stock Holding History

Jump Financial’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$881K Buy
+88,151
New +$668K 0.01% 1242
2025
Q3 		– Sell
-115,762
Closed -$564K – 2194
2025
Q2 		$564K Buy
115,762
+39,444
+52% +$139K 0.01% 1199
2025
Q1 		$282K Buy
+76,318
New +$327K ﹤0.01% 1316
2024
Q3 		– Sell
-41,590
Closed -$236K – 2068
2024
Q2 		$236K Buy
+41,590
New +$372K ﹤0.01% 1485
2021
Q3 		– Sell
-1,188
Closed -$65K – 1468
2021
Q2 		$65K Buy
+1,188
New +$78.5K 0.01% 1018

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's SLDB Position: Q2 2026 in Review

Jump Financial opened a new position in Solid Biosciences (SLDB) in Q2 2026: 88,151 shares worth $881K. The stake represents 0.01% of the portfolio and ranks #1242 among its holdings. This is a return to the name: Jump Financial previously reported a position in SLDB as recently as Q2 2025.

Jump Financial first reported a position in SLDB in Q2 2021 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Jump Financial held 88,151 shares of Solid Biosciences worth $881K as of Q2 2026.
  • Solid Biosciences was a new Jump Financial position in Q2 2026.
  • Solid Biosciences made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1242 holding.
  • Jump Financial first reported a position in Solid Biosciences in Q2 2021 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.